Abstract
Introduction: Paper describes our initial experience with transapical aortic valve implantation (TAP-AVI) the Edwards Sapien system. Methods and results: Out of 12 patients treated with transcatheter aortic valve implantation (TAVI), we have so far used transapical aortic valve implantation (TAP-AVI) in fi ve patients (transfemoral implantation was used in seven cases).
Periprocedural and 30-day mortality was zero in the whole group of our 12 patients. All patients treated using TAP-AVI have survived with improved clinical status.
Central regurgitation in one case was managed using the “valve-in-valve” strategy. We describe the procedure of implantation and possibility to manage complications we encountered.
Conclusion: Transapical aortic valve implantation is a safe therapeutical method with good results and acceptable risk. Our initial results of the transapical approach are encouraging